Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment with Ledipasvir and Sofosbuvir

Press/Media: Press / Media

PeriodJul 11 2016

Media coverage

1

Media coverage

  • TitlePrevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment with Ledipasvir and Sofosbuvir
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date7/11/16
    PersonsEric J Lawitz